Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Clinical trial NCT06954597 · RECRUITING
Trial details
- NCT number
- NCT06954597
- Sponsor
- Topadur Pharma AG
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-04
- Primary completion
- 2026-10-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.